Rinvoq (Upadacitinib Tablet) 15mg

Rinvoq (upadacitinib) 15mg tablets are used for managing inflammatory conditions like rheumatoid arthritis and psoriatic arthritis. This prescription medication helps reduce inflammation and joint damage. Store at room temperature and keep out of reach of children. Always follow your healthcare provider’s guidance.

Strength

15mg

Pack Size

28s

Storage

Ambient

Manufacturer / TM Owner

AbbVie Pty Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Rinvoq (upadacitinib) 15mg tablets are prescribed to treat moderate to severe rheumatoid arthritis in adults who haven’t responded well to other therapies. It is also used for active psoriatic arthritis and moderate to severe ulcerative colitis. This medication helps reduce joint pain, swelling, and stiffness while slowing joint damage. It belongs to a class of drugs that work on the immune system.

Side Effects

Many patients report reduced joint pain and improved mobility after starting Rinvoq (upadacitinib) 15mg. Some experience changes in energy levels and daily comfort as inflammation decreases. These effects may take several weeks to become noticeable. Individual responses can vary based on condition and treatment duration.

Precautions & Warnings

Rinvoq (upadacitinib) 15mg should be taken exactly as prescribed by a healthcare professional. Avoid use if you have a serious infection or are pregnant without consulting your doctor. Keep track of any new or worsening symptoms and report them promptly. Do not share this medication with others.

Avoid Interactions

Rinvoq (upadacitinib) 15mg may interact with other immunosuppressants, certain antibiotics, or medications that affect the immune system. Combining it with live vaccines is not recommended. Always inform your healthcare provider about all medications and supplements you’re taking to avoid potential interactions.

Frequently Asked Questions

Rinvoq (upadacitinib) 15mg is used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis.

Some patients notice improvements within a few weeks, but full effects may take longer.

Consult your doctor before combining Rinvoq with other drugs, especially immunosuppressants or live vaccines.

Rinvoq should only be used during pregnancy if clearly needed and under medical supervision.

Avoid close contact with people who have infections and do not receive live vaccines without consulting your doctor.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.